Skip to main content
. 2017 Jun;6(3):144–153. doi: 10.21037/hbsn.2016.08.06

Figure 1.

Figure 1

Comparison of the Kaplan-Meier survival curves of re-explored, resected patients (n=50; dotted line) and primarily R2 resected pancreatic cancer patients (n=101; full line). A log-rank test demonstrates improved survival in the re-explored patients compared to R2 margin status patients (P<0.001).